Social Sciences
dialysis patients
84%
end stage renal disease
78%
heart disease
43%
evidence
28%
clinical judgment
23%
event
19%
life expectancy
17%
clinician
14%
mortality
14%
lack
8%
literature
7%
Medicine & Life Sciences
Hydroxymethylglutaryl-CoA Reductase Inhibitors
67%
Renal Dialysis
60%
Chronic Kidney Failure
16%
Dialysis
16%
Kidney Diseases
13%
Secondary Prevention
12%
Guidelines
12%
Therapeutics
11%
Coronary Disease
11%
Primary Prevention
6%
Life Expectancy
6%
Dyslipidemias
6%
LDL Cholesterol
5%
Risk Assessment
5%
Meta-Analysis
4%
Randomized Controlled Trials
4%
Mortality
3%
Chemical Compounds
Dialysis
20%
Low-Density Lipoprotein Cholesterol
10%